Vaibhav Saini, PhD, enjoys technology transfer and business development activities to support early-stage research commercialization. Since 2023, he has been responsible for 90% of options and licenses at the Center for Research Innovation, Northeastern University. Previously, he performed business and technology development at MilliporeSigma, Merck KGaA. As Licensing Director for Life Sciences at the University of Connecticut, he encouraged academic-industry interactions and increased licensing and startup formation activities. As an Instructor in Medicine at Harvard Medical School, he researched hormonal regulation of osteoporosis, alopecia, and hepatic steatosis. Please feel free to reach out whenever you wish to talk science, business of science, and technology translation into products and services to benefit society.
